Stocks and InvestingStocks and Investing
Mon, March 11, 2024
Fri, March 8, 2024

Christopher Raymond Maintained (ALXO) at Buy with Increased Target to $21 on, Mar 8th, 2024


Published on 2024-10-28 09:34:50 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "ALX Oncology Holdings Inc." (ALXO) at Buy with Increased Target from $11 to $21 on, Mar 8th, 2024.

Christopher has made no other calls on ALXO in the last 4 months.



There is 1 other peer that has a rating on ALXO. Out of the 1 peers that are also analyzing ALXO, 0 agree with Christopher's Rating of Hold.



This is the rating of the analyst that currently disagrees with Christopher


  • Michael Yee of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $18 on, Friday, December 8th, 2023